• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     NIHR Horizon Scanning Centre (NIHR HSC) Abraxane for malignant melanoma – first line
2011     Blue Cross Blue Shield Association (BCBS) Computed tomographic coronary angiography in the evaluation of patients with acute chest pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines
2011     HAYES, Inc. Diaphragmatic/phrenic nerve stimulation
2011     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy
2011     NIHR Health Technology Assessment programme Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
2011     Blue Cross Blue Shield Association (BCBS) Special report: maintenance therapy in advanced non-small-cell lung cancer
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Safety of air vents in psychiatric units in a hospital setting: a review of the clinical evidence and guidelines
2011     HAYES, Inc. Endoscopic ultrasound (EUS) for diagnosis of pancreatic tumors
2011     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with octreotide (Sandostatin) for high risk carcinoid tumours – first or second line
2011     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) MALDI-TOF mass spectrometry for bacterial species identification: a review of diagnostic accuracy and clinical and cost-effectiveness
2011     HAYES, Inc. Endoscopic ultrasound (EUS) for locoregional staging of pancreatic tumors
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Ventilation/perfusion scintigraphy (using Technegas) versus computed tomography pulmonary angiography for the diagnosis of pulmonary embolism in hospitalized patients: a review of the clinical and cost-effectiveness
2011     HAYES, Inc. Endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNA) for diagnosis of pancreatic cancer
2011     Penn Medicine Center for Evidence-based Practice (CEP) Celecoxib for pain control in joint arthroplasty
2011     HAYES, Inc. High-frequency chest wall compression for diseases other than cystic fibrosis
2011     Medical Advisory Secretariat (MAS) Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis
2011     HAYES, Inc. Intranasal trivalent live attenuated influenza vaccine
2011     Health Information and Quality Authority (HIQA) A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
2011     Penn Medicine Center for Evidence-based Practice (CEP) Argon plasma coagulation for surgical procedures
2011     National Institute for Health and Care Excellence (NICE) Golimumab for the treatment of psoriatic arthritis. NICE technology appraisal guidance 220
2011     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Computerised cognitive behavioural therapy for adults with depression
2011     HAYES, Inc. Mechanical stretching devices for the treatment of joint contractures of the extremities
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with oxaliplatin, leucovorin and fluorouracil for colorectal cancer - adjuvant
2011     HAYES, Inc. testing
2011     National Institute for Health and Care Excellence (NICE) Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia. NICE technology appraisal guidance 218
2011     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Transnasal oesophagoscopy (TNE)
2011     HAYES, Inc. Nerve blocks for the treatment of chronic nonmalignant pain
2011     NIHR Horizon Scanning Centre (NIHR HSC) Brivanib for hepatocellular carcinoma – second line
2011     HAYES, Inc. title
2011     Adelaide Health Technology Assessment (AHTA) Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome
2011     National Institute for Health and Care Excellence (NICE) Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer. NICE technology appraisal guidance 214
2011     HAYES, Inc. Neuronavigation for intracranial biopsy and intracranial surgery
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with capecitabine and cisplatin for advanced or metastatic gastric cancer – first line
2011     National Institute for Health and Care Excellence (NICE) Bendamustine for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 216
2011     HAYES, Inc. Positron Emission Tomography (PET) and combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and initial staging of ovarian cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2011     National Institute for Health and Care Excellence (NICE) Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years. NICE technology appraisal guidance 213
2011     Medical Advisory Secretariat (MAS) Continuous glucose monitoring for patients with diabetes
2011     HAYES, Inc. Progesterone for the prevention of preterm birth
2011     NIHR Horizon Scanning Centre (NIHR HSC) EC145 for folate receptor positive ovarian cancer
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2011     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2011     Health Information and Quality Authority (HIQA) Health technology assessment of robot-assisted surgery in selected surgical procedures
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2011     NIHR Horizon Scanning Centre (NIHR HSC) Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for intracranial indications
2011     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for prostate cancer – second line
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for thoracic and abdominal indications
2011     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib with gemcitabine for advanced or metastatic pancreatic cancer
2011     Institute of Health Economics (IHE) Fecal transplantation for the treatment of clostridium difficile-associated disease or ulcerative colitis
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery (SRS) for spinal and extracranial head and neck indications
2011     NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel (Paclical) for epithelial ovarian cancer, fallopian tube cancer or peritoneal cancer – second or third line
2011     Medical Services Advisory Committee (MSAC) Use of artificial disc replacement in patients with cervical degenerative disc disease
2011     Institute for Clinical Evaluative Sciences (ICES) Geographic access to primary care and hospital services for rural and northern communities: Report to the Ontario Ministry of Health and Long-Term Care.
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dalcetrapib for the prevention of cardiovascular events
2011     Medical Services Advisory Committee (MSAC) Assessment of application for joint injections
2011     HAYES, Inc. HLA-B*27 testing for ankylosing spondylitis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Edoxaban tosylate for prevention of stroke and systemic embolic events in non-valvular atrial fibrillation
2011     Medical Services Advisory Committee (MSAC) Review of interim funded service: Hyperbaric Oxygen Therapy (HBOT) for the treatment of chronic non-diabetic wounds and non-neurological soft tissue radiation injuries
2011     Institute for Clinical Evaluative Sciences (ICES) Economic evaluation of percutaneous coronary intervention in stable coronary artery disease: studies in utilities, costs and decision modelling
2011     HAYES, Inc. KIT and PDGFRA testing for diagnosis of gastrointestinal stromal tumors (GISTs)
2011     NIHR Horizon Scanning Centre (NIHR HSC) HHLivC (Human Heterologous Liver Cells) for urea cycle disorders
2011     HAYES, Inc. KIT and PDGFRA testing for prognosis of gastrointestinal stromal tumors (GISTs)
2011     NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) HIFU for the treatment of prostate cancer
2011     Medical Services Advisory Committee (MSAC) Review of MBS Items for specific ophthalmology services under the MBS Quality Framework Stage 1
2011     HAYES, Inc. Leri-weill dyschondrosteosis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (MabThera) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis
2011     University of York Supporting women with postnatal depression through psychological therapies
2011     HAYES, Inc. Topoisomerase II alpha (TOP2A) testing to predict response to treatment of breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Odanacatib for post-menopausal osteoporosis – first or second line
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Abiraterone acetate (ZytigaTM) as 2nd-line therapy for the treatment of metastatic castration-resident prostate cancer after docetaxel therapy
2011     University of York Evidence briefing on specialist nurses in acute hospital settings
2011     HAYES, Inc. Canaloplasty (iTrack 250A canaloplasty microcatheter; iScience Interventional Inc.) for primary open-angle glaucoma
2011     NIHR Horizon Scanning Centre (NIHR HSC) Tocilizumab (RoACTEMRA) for early rheumatoid arthritis not treated with methotrexate – first line
2011     University of York Evidence briefing on nurse endoscopy
2011     HAYES, Inc. CellSearch circulating tumor cell (CTC) kit (Veridex LLC) for monitoring metastatic breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dimethyl fumarate for relapsing-remitting multiple sclerosis
2011     University of York Evidence briefing on integrated care pathways in mental health settings
2011     HAYES, Inc. C-leg prosthesis (Otto Bock HealthCare LP)
2011     NIHR Horizon Scanning Centre (NIHR HSC) Lacosamide (Vimpat) for epilepsy – first and second line
2011     HAYES, Inc. CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus for the treatment of unresectable or metastatic neuroendocrine tumours of pancreatic origin
2011     HAYES, Inc. Cooled radiofrequency denervation of the sacroiliac joint (pain management sInergy system, Baylis Medical Co. Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Guidelines and recommendations for ADHD in children and adolescents
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rituximab (Rituxan®/MabThera®) for the first- and second-line treatment of chronic lymphocytic leukaemia
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of the methodological instruments used in Health Technology Assessment
2011     HAYES, Inc. EsophyX system with srosaFuse fastener (EndoGastric Solutions) for endoluminal repair for gastroesophageal reflux disease (GERD)
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of economic evaluation on the use of PET-CT for cancer staging
2011     HAYES, Inc. Exhaled breath condensate pH testing for asthma management
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2011     HAYES, Inc. Ex-PRESS glaucoma filtration device (Alcon Inc.) for treatment of primary open-angle glaucoma
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Multidisciplinary treatment programs for patients with non-malignant pain: a review of the clinical evidence, cost-effectiveness, and guidelines
2011     HAYES, Inc. eXtreme lateral interbody fusion (XLIF; NuVasive Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Nabilone for chronic pain management: a review of clinical effectiveness, safety, and guidelines
2011     HAYES, Inc. Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in adults